What is the Average Weekly Weight Loss on Wegovy?

Last reviewed: June 22, 2026

Last updated: June 22, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Wegovy, works by slowing stomach emptying and activating brain centers that regulate hunger and fullness signals. Clinical trials show participants achieve an average weight loss of 15% of their body weight over 68 weeks, but the pace of loss varies significantly week to week. PlexusDx delivers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan through licensed 503A pharmacies, making precision GLP-1 therapy accessible without insurance requirements.

Typical Weekly Weight Loss Patterns on Semaglutide

During the first four weeks of semaglutide therapy, most patients experience rapid initial weight loss ranging from 1 to 2 pounds per week. This early phase reflects both water loss and reduced caloric intake from decreased appetite. However, weight loss is not always linear—some weeks show greater drops while others plateau as the body adapts to the medication and lifestyle changes.

By weeks 5 through 12, the average pace often slows to 0.5 to 1.5 pounds weekly as the body enters a more stable metabolic adjustment phase. Continued weight loss depends on maintaining consistent dosing, adhering to dietary guidelines, and engaging in regular physical activity. Patients who plateau may benefit from dose optimization or genetic insights into their individual peptide pathways, which PlexusDx assesses through its Precision Peptide Genetic Test.

Factors That Influence Your Personal Weight Loss Rate

Starting body weight plays a critical role in determining absolute weekly loss—individuals with higher initial weights typically see larger pound-per-week reductions in early months. Metabolic rate, determined partly by genetics and partly by age, sex, and muscle mass, affects how quickly the body burns calories even with appetite suppression. Your genetic predisposition at key peptide receptors, including GIPR variants, influences how effectively semaglutide engages your hunger-regulating pathways.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437) and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Wegovy or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Real Clinical Trial Data on Semaglutide Weight Loss

The STEP trials, which established Wegovy's efficacy, tracked weight loss across 68 weeks in over 4,500 participants with obesity or overweight plus comorbidities. Participants receiving the 2.4 mg weekly dose achieved a mean weight loss of 15.3% of their starting body weight, while placebo groups lost only 2.6%. Month-by-month breakdowns show cumulative losses of approximately 5 pounds by week 4, 12 pounds by week 8, and 18 pounds by week 16.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How PlexusDx Semaglutide Compares to Wegovy Pricing

Wegovy brand-name semaglutide often costs $900 to $1,300 monthly with insurance coverage or out-of-pocket, while PlexusDx compounded semaglutide injection starts at just $189/mo (or $149/mo on the 6-month plan) across all dosing levels. Your dose may need to go up—your price won't. PlexusDx medications originate from licensed 503A compounding pharmacies and serve all 50 states with no insurance requirement, no membership fees, and HSA/FSA eligibility.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Wegovy or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can I expect to lose 2 pounds every single week on semaglutide?

Weight loss is not perfectly linear week to week. You might lose 2 pounds one week and half a pound the next as your body adapts. Clinical data shows an average pace of 1 to 2 pounds weekly in early months, but individual weeks fluctuate based on hydration, sodium intake, hormonal cycles, and medication tolerance. Consistency over 4 to 8 weeks gives a clearer picture of your true loss trajectory.

How much weight can I realistically lose in three months on semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Why does weight loss on semaglutide slow down after a few months?

Your body naturally adapts to appetite suppression as you lose weight and the medication normalizes your hunger signals. Additionally, a lower body weight requires fewer calories to maintain, so your caloric deficit shrinks unless you increase activity or further restrict intake. Dose escalation, dietary adjustment, or adding complementary peptide therapy through PlexusDx's GLP-Squared options can help restart momentum when plateaus occur.

Are there side effects that might slow my weight loss on semaglutide?

Gastrointestinal side effects like nausea or constipation can reduce food intake beyond the medication's appetite-suppressing effect, sometimes accelerating early loss but potentially becoming unsustainable. Conversely, if side effects discourage consistent dosing or dietary adherence, they may hinder your overall progress. PlexusDx compounding pharmacies can adjust formulations and delivery methods—such as switching to oral semaglutide—to improve tolerability while maintaining efficacy.

Can genetic testing tell me if I'll be a fast or slow responder to semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to Wegovy or any specific medication. It analyzes pathway-level variants (GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy For Weight Loss 2
• Average Weight Loss On Ozempic
• Wegovy Weight Loss Pills
• Wegovy Vs Zepbound Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.